6/5/13

Pyridostigmine

Pyridostigmine [peer-id-oh-STIG-meen] and ambenomium [am-be-NOE-mee-um] are other cholinesterase inhibitors that are used in the chronic management of myasthenia gravis. Their durations of action are intermediate (3 to 6 hours and 4 to 8 hours, respectively), but longer than that of neostigmine. Adverse effects of these agents are similar to those of neostigmine.


No comments:

Post a Comment